Guest guest Posted August 2, 2011 Report Share Posted August 2, 2011 Vertex Reports Second Quarter 2011 Financial Results and Provides Updates on Launch of INCIVEK (telaprevir) and Development Programs From the PharmaLive.com News Archive - Jul. 28, 2011 Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the quarter ended June 30, 2011 and provided an update on the launch of INCIVEK (telaprevir) tablets and its development programs. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.